-
Nosa Plugs ABs delårsrapport för första kvartalet 2025
VD har ordet Stabil startVi fortsätter att växa kraftigt i såväl B2B som B2C-kanalerna, samtidigt som vi nu visar positivt kassaflöde. Vi har under kvartalet visat att vi både kan växa snabbt och lönsamt. Omsättningstillväxten om +50% är i linje med den långsiktiga trenden och speglar en fortsatt stark efterfrågan av våra produkter. Under kvartalet …
More -
Nosa Plugs ABs delårsrapport för första kvartalet 2024
VD har ordetVi inleder året lika starkt som vi avslutade föregående år. Med en stabil underliggande tillväxt hos befintliga kunder, i kombination med en ny tillväxtmotor i form av Smell training, ser vi en fortsatt långsiktigt intakt försäljningsutveckling. I jämförelse med föregående års förhållandevis starka jämförelsesiffror, är den blygsamma omsättningsökningen om 34 % okej, men …
More -
Correction: Interim Report Q1, 2022
The correction refers to the EU Market Abuse Regulation. CEO StatementDuring the quarter, we have expanded our cooperation with the private healthcare provider, Capio. In addition to the multi-year agreement with Capio Elderly and Mobile Care, Capio Orthopedics signed a 3-year agreement with us. The new agreement was signed after a successful pilot project, which …
More -
Interim Report Q1, 2022
CEO StatementDuring the quarter, we have expanded our cooperation with the private healthcare provider, Capio. In addition to the multi-year agreement with Capio Elderly and Mobile Care, Capio Orthopedics signed a 3-year agreement with us. The new agreement was signed after a successful pilot project, which really proves that FRISQ Care brings value that our …
More -
Interim Report Q1, 2021 – Turnover exceeding previous full year
CEO Statement The pandemic continues to affect our industry in many ways. But although the room for long-term digitalisation decisions is small right now, FRISQ’s pilot projects continue to run as planned or better. Our clients’ innovation continue to depend heavily on FRISQ Care and we have in several instances been asked to increase our …
More -
Interim Report Q1, 2020
Federal stamp of approval creates opportunities in a turbulent time. FRISQ – the only digital solution that meets the requirements for the patient contract CEO statementDuring the first three months of the year we conducted an over-subscribed preferential rights issue of approximately 74.6 MSEK, as well as many business development initiatives with customers in Sweden …
More